TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. purchase Customization

purchase customization

Leave This Empty:

choose chapter to purchase


Back to Report

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Allogeneic Stem Cell Transplantation
1.2 Key Market Segments
1.2.1 Allogeneic Stem Cell Transplantation Segment by Type
1.2.2 Allogeneic Stem Cell Transplantation Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Allogeneic Stem Cell Transplantation Market Overview
2.1 Global Market Overview
2.1.1 Global Allogeneic Stem Cell Transplantation Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Allogeneic Stem Cell Transplantation Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Allogeneic Stem Cell Transplantation Market Competitive Landscape
3.1 Global Allogeneic Stem Cell Transplantation Sales by Manufacturers (2019-2024)
3.2 Global Allogeneic Stem Cell Transplantation Revenue Market Share by Manufacturers (2019-2024)
3.3 Allogeneic Stem Cell Transplantation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Allogeneic Stem Cell Transplantation Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Allogeneic Stem Cell Transplantation Sales Sites, Area Served, Product Type
3.6 Allogeneic Stem Cell Transplantation Market Competitive Situation and Trends
3.6.1 Allogeneic Stem Cell Transplantation Market Concentration Rate
3.6.2 Global 5 and 10 Largest Allogeneic Stem Cell Transplantation Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Allogeneic Stem Cell Transplantation Industry Chain Analysis
4.1 Allogeneic Stem Cell Transplantation Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Allogeneic Stem Cell Transplantation Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Allogeneic Stem Cell Transplantation Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Allogeneic Stem Cell Transplantation Sales Market Share by Type (2019-2024)
6.3 Global Allogeneic Stem Cell Transplantation Market Size Market Share by Type (2019-2024)
6.4 Global Allogeneic Stem Cell Transplantation Price by Type (2019-2024)
7 Allogeneic Stem Cell Transplantation Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Allogeneic Stem Cell Transplantation Market Sales by Application (2019-2024)
7.3 Global Allogeneic Stem Cell Transplantation Market Size (M USD) by Application (2019-2024)
7.4 Global Allogeneic Stem Cell Transplantation Sales Growth Rate by Application (2019-2024)
8 Allogeneic Stem Cell Transplantation Market Segmentation by Region
8.1 Global Allogeneic Stem Cell Transplantation Sales by Region
8.1.1 Global Allogeneic Stem Cell Transplantation Sales by Region
8.1.2 Global Allogeneic Stem Cell Transplantation Sales Market Share by Region
8.2 North America
8.2.1 North America Allogeneic Stem Cell Transplantation Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Allogeneic Stem Cell Transplantation Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Allogeneic Stem Cell Transplantation Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Allogeneic Stem Cell Transplantation Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Allogeneic Stem Cell Transplantation Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Mesoblast Limited
9.1.1 Mesoblast Limited Allogeneic Stem Cell Transplantation Basic Information
9.1.2 Mesoblast Limited Allogeneic Stem Cell Transplantation Product Overview
9.1.3 Mesoblast Limited Allogeneic Stem Cell Transplantation Product Market Performance
9.1.4 Mesoblast Limited Business Overview
9.1.5 Mesoblast Limited Allogeneic Stem Cell Transplantation SWOT Analysis
9.1.6 Mesoblast Limited Recent Developments
9.2 Gamida Cell Ltd.
9.2.1 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Basic Information
9.2.2 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Product Overview
9.2.3 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Product Market Performance
9.2.4 Gamida Cell Ltd. Business Overview
9.2.5 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation SWOT Analysis
9.2.6 Gamida Cell Ltd. Recent Developments
9.3 Novartis International AG
9.3.1 Novartis International AG Allogeneic Stem Cell Transplantation Basic Information
9.3.2 Novartis International AG Allogeneic Stem Cell Transplantation Product Overview
9.3.3 Novartis International AG Allogeneic Stem Cell Transplantation Product Market Performance
9.3.4 Novartis International AG Allogeneic Stem Cell Transplantation SWOT Analysis
9.3.5 Novartis International AG Business Overview
9.3.6 Novartis International AG Recent Developments
9.4 Cellectis SA
9.4.1 Cellectis SA Allogeneic Stem Cell Transplantation Basic Information
9.4.2 Cellectis SA Allogeneic Stem Cell Transplantation Product Overview
9.4.3 Cellectis SA Allogeneic Stem Cell Transplantation Product Market Performance
9.4.4 Cellectis SA Business Overview
9.4.5 Cellectis SA Recent Developments
9.5 Magenta Therapeutics Inc.
9.5.1 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Basic Information
9.5.2 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Overview
9.5.3 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Market Performance
9.5.4 Magenta Therapeutics Inc. Business Overview
9.5.5 Magenta Therapeutics Inc. Recent Developments
9.6 Fate Therapeutics Inc.
9.6.1 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Basic Information
9.6.2 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Overview
9.6.3 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Market Performance
9.6.4 Fate Therapeutics Inc. Business Overview
9.6.5 Fate Therapeutics Inc. Recent Developments
9.7 Cynata Therapeutics Limited
9.7.1 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Basic Information
9.7.2 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Product Overview
9.7.3 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Product Market Performance
9.7.4 Cynata Therapeutics Limited Business Overview
9.7.5 Cynata Therapeutics Limited Recent Developments
9.8 Kiadis Pharma N.V
9.8.1 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Basic Information
9.8.2 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Product Overview
9.8.3 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Product Market Performance
9.8.4 Kiadis Pharma N.V Business Overview
9.8.5 Kiadis Pharma N.V Recent Developments
9.9 Takeda Pharmaceutical Company Limited
9.9.1 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Basic Information
9.9.2 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Product Overview
9.9.3 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Product Market Performance
9.9.4 Takeda Pharmaceutical Company Limited Business Overview
9.9.5 Takeda Pharmaceutical Company Limited Recent Developments
9.10 JCR Pharmaceuticals Co., Ltd.
9.10.1 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Basic Information
9.10.2 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Product Overview
9.10.3 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Product Market Performance
9.10.4 JCR Pharmaceuticals Co., Ltd. Business Overview
9.10.5 JCR Pharmaceuticals Co., Ltd. Recent Developments
9.11 Pluristem Therapeutics Inc.
9.11.1 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Basic Information
9.11.2 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Overview
9.11.3 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Market Performance
9.11.4 Pluristem Therapeutics Inc. Business Overview
9.11.5 Pluristem Therapeutics Inc. Recent Developments
9.12 Celularity Inc.
9.12.1 Celularity Inc. Allogeneic Stem Cell Transplantation Basic Information
9.12.2 Celularity Inc. Allogeneic Stem Cell Transplantation Product Overview
9.12.3 Celularity Inc. Allogeneic Stem Cell Transplantation Product Market Performance
9.12.4 Celularity Inc. Business Overview
9.12.5 Celularity Inc. Recent Developments
9.13 Lineage Cell Therapeutics Inc.
9.13.1 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Basic Information
9.13.2 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Overview
9.13.3 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Market Performance
9.13.4 Lineage Cell Therapeutics Inc. Business Overview
9.13.5 Lineage Cell Therapeutics Inc. Recent Developments
9.14 Nohla Therapeutics Inc.
9.14.1 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Basic Information
9.14.2 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Overview
9.14.3 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Market Performance
9.14.4 Nohla Therapeutics Inc. Business Overview
9.14.5 Nohla Therapeutics Inc. Recent Developments
9.15 Orchard Therapeutics Plc
9.15.1 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Basic Information
9.15.2 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Product Overview
9.15.3 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Product Market Performance
9.15.4 Orchard Therapeutics Plc Business Overview
9.15.5 Orchard Therapeutics Plc Recent Developments
10 Allogeneic Stem Cell Transplantation Market Forecast by Region
10.1 Global Allogeneic Stem Cell Transplantation Market Size Forecast
10.2 Global Allogeneic Stem Cell Transplantation Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Allogeneic Stem Cell Transplantation Market Size Forecast by Country
10.2.3 Asia Pacific Allogeneic Stem Cell Transplantation Market Size Forecast by Region
10.2.4 South America Allogeneic Stem Cell Transplantation Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Allogeneic Stem Cell Transplantation by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Allogeneic Stem Cell Transplantation Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Allogeneic Stem Cell Transplantation by Type (2025-2030)
11.1.2 Global Allogeneic Stem Cell Transplantation Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Allogeneic Stem Cell Transplantation by Type (2025-2030)
11.2 Global Allogeneic Stem Cell Transplantation Market Forecast by Application (2025-2030)
11.2.1 Global Allogeneic Stem Cell Transplantation Sales (K Units) Forecast by Application
11.2.2 Global Allogeneic Stem Cell Transplantation Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings